Chemed Co. (NYSE:CHE) VP Purchases $75,327.50 in Stock

Chemed Co. (NYSE:CHE) VP Brian C. Judkins purchased 145 shares of the business’s stock in a transaction on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Chemed Stock Up 0.4 %

CHE opened at $529.80 on Thursday. The company has a market capitalization of $7.97 billion, a PE ratio of 26.77, a price-to-earnings-growth ratio of 2.32 and a beta of 0.46. The firm has a 50-day simple moving average of $551.77 and a two-hundred day simple moving average of $562.94. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.32 EPS. As a group, sell-side analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date was Monday, November 18th. Chemed’s payout ratio is 10.11%.

Hedge Funds Weigh In On Chemed

Institutional investors and hedge funds have recently made changes to their positions in the business. American National Bank & Trust bought a new position in shares of Chemed in the 3rd quarter valued at about $61,000. GAMMA Investing LLC raised its position in Chemed by 60.5% during the third quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock valued at $83,000 after purchasing an additional 52 shares during the period. Quarry LP lifted its stake in shares of Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares during the last quarter. Sound Income Strategies LLC purchased a new position in shares of Chemed in the 3rd quarter worth approximately $201,000. Finally, Farther Finance Advisors LLC increased its position in shares of Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock valued at $203,000 after purchasing an additional 324 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.